08158

中國再生醫學

• PUBT·5d ago

  Bridgepoint agrees to buy Waldencast’s Obagi Medical skincare business

• PUBT·06/01 10:59

  Waldencast agrees to sell Obagi Medical to Bridgepoint for up to $460 million

• PUBT·05/15 12:13

  Waldencast Obagi shares interim ALOHA trial data for Saypha MagIQ dermal filler

• PUBT·04/30 10:09

  CRMI proposes bylaw changes to allow hybrid shareholder meetings, e-voting

• PUBT·04/28 21:29

  Waldencast says SEC ends probe, plans no enforcement action

• Simply Wall St·03/29 00:14

  Is Now The Time To Put China Regenerative Medicine International (HKG:8158) On Your Watchlist?

• Reuters·03/27 12:13

  China Regenerative Medicine International FY2025 profit rises to HK$27.53 million; revenue drops 20.48% to HK$72.06 million

• Reuters·03/27 12:12

  CHINA REGENERATIVE MEDICINE INTERNATIONAL FY NET INCOME ATTRIBUTABLE HKD 27.5 MILLION

• Reuters·03/27 12:12

  CHINA REGENERATIVE MEDICINE INTERNATIONAL FY REVENUE HKD 72.06 MILLION

• Reuters·03/25 13:51

  China Regenerative Medicine International FY2025 profit attributable to owners rises at least 28% due to income tax credit from prior-year overprovision

• Reuters·03/19 12:29

  Obagi Medical partners with ProMD Health in ALOHA Program to evaluate saypha MagIQ

• Reuters·03/13 11:02

  UK’s Waldencast posts flat Q4 revenue on Milk Makeup weakness, withholds outlook

• Reuters·02/27 13:33

  Waldencast's Obagi and Schweiger Dermatology launch ALOHA Phase 4 study of saypha MagIQ injectable

• Reuters·02/25 13:26

  Obagi Medical Partners With It’s a Secret Med Spa in ALOHA Program for saypha MagIQ

• Reuters·02/17 13:28

  Waldencast Partners with Aesthetic Record for Obagi ALOHA Program